STK3 and neoplasm: Upon deeper analysis of STK3 expression patterns in GC patients, we unveiled a frequent amplification of STK3 and significant correlation with poorer clinical outcomes, suggesting that this widely recognized tumor suppressor gene may exhibit oncogenic properties in GC progression.